top
Please input keywords
Order
*Country
한국
미국
일본
중국
영국
호주
프랑스
독일
이탈리아
싱가포르
인도
러시아
캐나다
스위스
기타 국가
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-mSiglec15 MC38
Common name
B-mSiglec15 MC38 Catalog number    311529
Aliases Cd33l, Cd33l3, EG620235, SIGLEC-I Disease  Colon carcinoma
Organism
Mouse
Strain  C57BL/6
Tissue types Colon Tissue  Colon

Description


The mouse Siglec15 gene was insert into mouse ROSA26 site. Mouse Siglec15 is highly expressed on the surface of B-mSiglec15 MC38 cells.


Application


B-mSiglec15 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.



Targeting strategy

Gene targeting strategy for B-mSiglec15 MC38.The mouse Siglec15 CDS was insert into mouse ROSA26 site in B-mSiglec15 MC38. 

Protein expression analysis


from clipboard


The Siglec15 expression analysis in B-mSiglec15 MC38 cells by flow cytometry. Single cells were collected from wild-type MC38 and B-mSiglec15 MC38 cells, and analyzed by flow cytometry with anti-human and mouse SIGLEC15 antibody(SIGLEC15-5G12, in house). Mouse Siglec15 was exclusively detectable in B-mSiglec15 MC38 cells but not wild-type MC38 cells. The 2-C12 clone of B-mSiglec15 MC38 cells was used for in vivo experiments.

Tumor growth curve & Body weight changes

from clipboard


Subcutaneous homograft tumor growth of B-mSiglec15 MC38 cells. B-mSiglec15 MC38 cells (5x105) and wild-type MC38 cells (5x105 ) were subcutaneously implanted into the C57BL/6N mice (female, 5-8 week-old, n=5).Tumor size and mice body weight were measured twice a week. (A) Tumor average volume ± SEM, (B) Mice body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5a X b2, where a and b were the long and short diameters of the tumor, respectively. As shown in panel A, B-mSiglec15 MC38 were able to establish tumor in vivo and can be used for efficacy studies.


Tumor growth curve of individual mice


from clipboard

B-mSiglec15 MC38 tumor cells growth of individual mice. B-mSiglec15 MC38 cells (5x105) and wild-type MC38 cells (5x105 ) were subcutaneously implanted into the C57BL/6N mice (female, 5-8 week-old, n=5). As shown in panel, B-mSiglec15 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.


Protein expression analysis of tumor cells


from clipboard

B-mSiglec15 MC38 cells were transplanted into C57BL/6N mice (n=5), and on 28 days post inoculation, certain volumes of tumors as  was taken to detect the expression level of the cells. Cells were analyzed by flow cytometry with anti-human and mouse SIGLEC15 antibody(SIGLEC15-5G12, in house). As shown, mouse Siglec15 was highly expressed on the surface of B-mSiglec15 MC38 tumor cells. B-mSiglec15 MC38 can be used for in vivo efficacy validation.